HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of tosufloxacin in genital chlamydial infections].

Abstract
According to the 2006 and 2008 "Guidelines for diagnosis and treatment of sexually transmitted diseases" by the Japanese Society for Sexually Transmitted Diseases, quinolones, macrolides and tetracyclines are recommended to treat chlamydial infections. The administration method based on pharmacokinetic/pharmacodynamic theory, as well as the selection of antimicrobial drugs, is important in antimicrobial therapy. It is currently assumed that the efficacy of administering high-dose quinolones once a day is greater than dividing the dose over multiple administrations. To verify the treatment effects of the recommended tosufloxacin dose of 150 mg b.i.d. (300 mg/day) for 7 days, we performed a comparative multicenter open label study of 150 mg b.i.d. and 300 mg q.d. (300 mg/day). The results indicated complete efficacy with 100% (150 mg b.i.d.: 49/49, 300 mg q.d.: 57/57) eradication of Chlamydia trachomatis at both dosages. The clinical efficacy was "markedly effective" in 57.1% (28/49) of cases, "effective" in 42.9% (21/49), and "not effective" in 0% (0/49) in the 150 mg b.i.d. group, while these values were 59.6% (34/57), 40.4% (23/57) and 0% (0/57), respectively, in the 300 mg q.d. group. Quinolone therapy for genital chlamydial infections with tosufloxacin doses of 150 mg b.i.d. was confirmed to be effective as recommended in the guidelines. Moreover, tosufloxacin at 300 mg q.d. was shown to be an effective therapy.
AuthorsHiroshige Mikamo, Yuka Yamagishi, Kaori Tanaka, Kunitomo Watanabe, Michihisa Fujiwara, Kazuhiro Iwasaku, Koji Izumi, Keiichi Takahashi, Ken Nakabe, Kenji Nozawa
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 62 Issue 5 Pg. 406-14 (Oct 2009) ISSN: 0368-2781 [Print] Japan
PMID20055118 (Publication Type: Comparative Study, English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Naphthyridines
  • tosufloxacin
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Animals
  • Anti-Bacterial Agents (administration & dosage)
  • Chlamydia Infections (drug therapy)
  • Chlamydia trachomatis
  • Drug Administration Schedule
  • Female
  • Fluoroquinolones (administration & dosage)
  • Genital Diseases, Female (drug therapy)
  • Humans
  • Naphthyridines (administration & dosage)
  • Practice Guidelines as Topic
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: